Centre for Systems Biology in Shanghai

Agilent Technologies announced that together with the Shanghai Institute of Biological Sciences (SIBS), the company has opened the joint SIBS-Agilent Centre for Systems Biology in Shanghai, China. The centre will conduct research in the areas of genomics, proteomics and metabolomics and will use multiple technology platforms to conduct biomarker identification to better understand diseases.

“Agilent is very proud to be collaborating with world-class life science researchers who are contributing to breakthrough research in China,” said Nick Roelofs, president of Agilent’s Life Sciences Group. “China has demonstrated tremendous progress in recent years in technological advancement and research capabilities.”

“This is more than a simple technical collaboration. It is an opportunity for scientists in China to work together with a company providing advanced technologies,” said Professor Wu Jiarui, vice president of SIBS. “Agilent not only provides us with the technology tools, but we also look forward to close interaction with their scientists and the life science community in China. I am confident this collaboration will be a tremendous success.”

The centre is equipped with the latest products in the company’s portfolio including the Q-TOF, LC–QQQ, Chip-LC, GC–MS and HPLC platforms.

“This is the first system biology joint laboratory with Agilent in China, backed with a broad scope of scientific talents and a comprehensive portfolio of genomics, proteomics, metabolomics and bioinformatics tools,” said Yiping Mu, general manager of Greater China for the company. “This is a perfect marriage of the strengths from both organizations. We are looking forward to a long-term and productive collaboration that will strengthen Agilent’s presence in China.”

Information about the company is available on-line at www.agilent.com